UF Scripps Scientists To Receive $15 Million To Help Fight Current and Future Pandemics

Multiple scientists from UF Scripps Biomedical Research will join a massive federal effort to develop antiviral drugs to treat the pandemic coronavirus and other viral threats.

Announcing its $577 million effort to stock the nation’s medicine chest with new treatments for dangerous viral diseases, the National Institute of Allergy and Infectious Disease announced last week that it is establishing nine multi-institution centers focused on developing new medications to address the ongoing COVID-19 crisis, and to treat other viruses with pandemic potential.

Seven UF Scripps scientists plus an engineer will contribute to three of those centers. The federal agency calls the groups “Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern,” or AViDD. The AViDD grant awards to UF Scripps-directed projects and scientific core services could total more than $15 million over the next three to five years.

Learn more about UF Scripps Scientists To Receive $15 Million To Help Fight Current and Future Pandemics